search
Back to results

Patient Portal - Flu Reminder Recall

Primary Purpose

Influenza, Respiratory Tract Infections, Vaccines

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
1 MyChart R/R
2 MyChart R/R
3 MyChart R/R
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Influenza focused on measuring Reminder Recall (R/R), Influenza Vaccine, Electronic Health Record

Eligibility Criteria

4 Months - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

• A patient within the UCLA Health System identified by the system as a primary care patient per an internal algorithm, with a documented primary care visit within the last 3 years as of 8/1/18.

Exclusion Criteria:

• A patient not identified by the UCLA Health System's internal algorithm as a primary care patient.

Sites / Locations

  • University of California, Los Angeles

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Standard of care control

1 MyChart R/R

2 MyChart R/R

3 MyChart R/R

Arm Description

Participants in this group will not receive any MyChart influenza vaccination reminders

Participants in this group will receive up to 1 influenza reminder recall notice via their MyChart account

Participants in this group will receive up to 2 influenza reminder recall notices via their MyChart account

Participants in this group will receive up to 3 influenza reminder recall notices via their MyChart account

Outcomes

Primary Outcome Measures

1.Receipt of the Annual Influenza Vaccine (Between 10/1/18 - 4/2/19) Among Index Patients. Outcomes Will be Assessed Via Vaccine Data Extraction From the Electronic Health Record and External Claims and Pharmacy Data.
Number of participants in each arm who received influenza vaccination

Secondary Outcome Measures

Full Information

First Posted
September 7, 2018
Last Updated
November 12, 2021
Sponsor
University of California, Los Angeles
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
search

1. Study Identification

Unique Protocol Identification Number
NCT03666026
Brief Title
Patient Portal - Flu Reminder Recall
Official Title
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
October 2, 2018 (Actual)
Primary Completion Date
April 2, 2019 (Actual)
Study Completion Date
April 2, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and >65 yrs. (63%). The investigators will assess the effectiveness and cost-effectiveness of 1, 2, 3 MyChart R/R messages as compared to the standard of care control (no messages).
Detailed Description
Annual epidemics of influenza cause substantial morbidity in the U.S. with up to 40,000 deaths/year and many hospitalizations, emergency and outpatient visits, and significant costs. Concerns about pandemic influenza elevate the need to prevent flu outbreaks. Numerous studies, including Cochrane or systematic reviews, and reports by the CDC and the Task Force on Community Preventive Services, highlight 4 evidence-based strategies to raise child and adult influenza vaccination rates: 1) increase patient demand by reminder-recall or education, 2) expand patient access to influenza vaccinations (e.g., flu vaccine clinics), 3) implement provider strategies such as prompts or standing orders, and 4) use societal strategies (e.g., reducing costs). Reminder/recall (R/R), sent by phone, mail or other modality, can improve child and adult influenza vaccination rates. However, fewer than one-fifth of pediatric or adult primary care practices utilize patient R/R. Barriers are lack of finances, personnel, and algorithms to identify eligible patients. A technological breakthrough that might overcome these barriers involves patient portals-- secure, web-based communication systems, embedded within electronic health records (EHRs), for patients and providers to communicate with each other via email and the internet. Portals are used by about half of Americans and half of UCLA patients. Portals can theoretically improve upon phone, mail or text R/R by adding information such as web links, videos, or images, allowing patients to schedule their own visits, and linking to the medical chart to customize messages. For this randomized control trial, the intent is to evaluate the impact of patient portal (MyChart) reminder recalls - either 1, 2, or 3 reminders versus the standard of care control group, specifically in relation to raising influenza vaccination rates among UCLA Health System's primary care patients aged 6 months and older. The proposed design of this 4-arm RCT: Standard of care control (no messages) Up to 1 portal R/R messages Up to 2 portal R/R messages Up to 3 portal R/R messages Hypothesis 1: >1 portal R/R will increase vaccination rates vs. no R/R. Hypothesis 2: More R/R messages will raise vaccination rates (3R/R > 2R/R > 1R/R > 0R/R). For the primary analysis, only the data from the randomly selected index patients (1 index patient per household) will be included. For relevant study arms, the first R/R message will be sent in October 2018.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Influenza, Respiratory Tract Infections, Vaccines
Keywords
Reminder Recall (R/R), Influenza Vaccine, Electronic Health Record

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
164205 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard of care control
Arm Type
No Intervention
Arm Description
Participants in this group will not receive any MyChart influenza vaccination reminders
Arm Title
1 MyChart R/R
Arm Type
Experimental
Arm Description
Participants in this group will receive up to 1 influenza reminder recall notice via their MyChart account
Arm Title
2 MyChart R/R
Arm Type
Experimental
Arm Description
Participants in this group will receive up to 2 influenza reminder recall notices via their MyChart account
Arm Title
3 MyChart R/R
Arm Type
Experimental
Arm Description
Participants in this group will receive up to 3 influenza reminder recall notices via their MyChart account
Intervention Type
Behavioral
Intervention Name(s)
1 MyChart R/R
Intervention Description
Up to 1 flu vaccine reminder recall notice sent via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.
Intervention Type
Behavioral
Intervention Name(s)
2 MyChart R/R
Intervention Description
Up to 2 flu vaccine reminder recall notices sent every 3-4 weeks via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.
Intervention Type
Behavioral
Intervention Name(s)
3 MyChart R/R
Intervention Description
Up to 3 flu vaccine reminder recall notices sent every 3-4 weeks via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.
Primary Outcome Measure Information:
Title
1.Receipt of the Annual Influenza Vaccine (Between 10/1/18 - 4/2/19) Among Index Patients. Outcomes Will be Assessed Via Vaccine Data Extraction From the Electronic Health Record and External Claims and Pharmacy Data.
Description
Number of participants in each arm who received influenza vaccination
Time Frame
October 1, 2018 to April 2, 2019 during influenza vaccination season

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • A patient within the UCLA Health System identified by the system as a primary care patient per an internal algorithm, with a documented primary care visit within the last 3 years as of 8/1/18. Exclusion Criteria: • A patient not identified by the UCLA Health System's internal algorithm as a primary care patient.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Szilagyi, MD MPH
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Aggregate results will be prepared for publication at the end of the trial.
Citations:
PubMed Identifier
32421168
Citation
Szilagyi PG, Albertin C, Casillas A, Valderrama R, Duru OK, Ong MK, Vangala S, Tseng CH, Rand CM, Humiston SG, Evans S, Sloyan M, Lerner C. Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial. JAMA Intern Med. 2020 Jul 1;180(7):962-970. doi: 10.1001/jamainternmed.2020.1602.
Results Reference
derived

Learn more about this trial

Patient Portal - Flu Reminder Recall

We'll reach out to this number within 24 hrs